Componed, I didnt realize it was only a 28 day test. That is not too much of a hold up as long as they can get lab space soon. I just hope the patients that were ready to enter the trial are still around. Barley, I wish I had bought in the same time as you. It is amazing that the only Australian drug to ever show robust responses against stage4 refractory tumours in the first phase1 trial could be entering the phase 2 trials, against the target cancers, at this price. I am not complaining though. Always do your own DD.
Good luck to holders.
SBP
solbec pharmaceuticals limited
pfizers failed tlr9 trial, page-8
Add to My Watchlist
What is My Watchlist?